The company is a specialized platform focusing on the R&D, production, and supply of medical isotopes. With the core direction of "integrated diagnosis and therapy, precise targeted treatment," it provides customers with stable and reliable medical isotope products and solutions. In response to the development trends of nuclear medicine and market demands, CGN Isotope Company adheres to independent innovation, breaks through key technologies, and has built autonomous production capabilities for a variety of critical medical isotopes, including Ge-68, Ge-68/Ga-68 generators, Cu-64, Zr-89, and I-123, supporting the innovative R&D and clinical application of radiopharmaceuticals.